The Korean Journal of Nuclear Medicine (대한핵의학회지)

The Korean Society of Nuclear Medicine (대한핵의학회)
권호 표지

Safety and Feasibility of Thallium-201 Myocardial SPECT with Intravenous Infusion of Disodium Adenosine Triphosphate (ATP) in the Diagnosis of Coronary Artery disease

관상동맥 질환 진단에서 ATP부하 T1-201 심근 관류 SPECT의 안전성과 유용성

  • Pai, Moon-Sun (Departments of Nuclear Medicine, Ajou University College of Medicine) ;
  • Park, Chan-H. (Departments of Nuclear Medicine, Ajou University College of Medicine) ;
  • Yoon, Seok-Nam (Departments of Nuclear Medicine, Ajou University College of Medicine) ;
  • Kim, Won (Departments of Cardiology, Ajou University College of Medicine) ;
  • Kim, Han-Soo (Departments of Cardiology, Ajou University College of Medicine)
  • 배문선 (아주대학교 의과대학 핵의학교실) ;
  • 박찬희 (아주대학교 의과대학 핵의학교실) ;
  • 윤석남 (아주대학교 의과대학 핵의학교실) ;
  • 김원 (아주대학교 의과대학 순환기 내과학교실) ;
  • 김한수 (아주대학교 의과대학 순환기 내과학교실)
  • Published : 1998.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: ATP (adenosine triphosphate) is a potent coronary vasodilator with a rapid onset of action and a very short half-life. Myocardial perfusion scintigraphy with intravenous ATP has not yet been sufficiently proven in the diagnosis, follow-up, and risk stratification of coronary artery disease. The purpose of this study was to evaluate the safety, feasibility and diagnostic accuracy of pharmacologic stress thallium-201 myocardial SPECT using an intra-venous ATP infusion in patients with suspected coronary artery disease. Materials and Methods: Thallium-201 myocardial SPECT in 319 patients with suspected coronary artery disease were performed after the infusion of ATP (0.08 mg/kg/min for 6 min). The adverse effects were carefully monitored. Coronary angiography was also performed within 3 weeks. Results: Although 76.5% of the patients had some adverse effects, they were transient, mild, and well tolerated. In all patients, the ATP infusion protocol was completed and only 2 patients required aminophylline. The adverse effects were dyspnea in 63%, headache in 31%, flushing in 21%, chest pain in 14% and abdominal discomfort in 5% of the patients. The sensitivity and specificity were 80% and 90% respectively. Conclusion: Thallium-201 myocardial SPECT after 6 min-infusion of ATP at a rate of 0.08 mg/kg/min is safe and has a diagnostic value in detecting coronary artery disease.

목적 : ATP는 작용 시간이 빠르고 반감기가 짧은 효과적인 관상동맥 확장제로 알려져 있어 이를 심근관류 SPECT의 부하 약물로 사용 할 때에 부작용의 빈도와 안전성, 그 진단적 가치에 대해 알아 보고자하였다. 대상 및 방법: 관상동맥 질환이 의심되는 319명의 환자를 대상으로 ATP 부하(0.08 mg/kg/ min for 6min) T1-201 심근관류 SPECT를 실시하여 그 부작용을 조사하고 관상동맥 조영술과 비교하였다. 결과: 76.5%의 환자에서 부작용이 발생하였으나 일시적이고 경미하였으며, 모든 환자에서 ATP 주입을 끝낼 수 있었고 aminophylline이 필요했던 환자는 2명이었다. 관상동맥 조영술과 비교한 결과, 예민도 80%, 특이도 90% 였다. 결론: 6분간 0.08mg/kg/min의 ATP 주입 용량을 사용한 본 연구 결과에서 ATP 부하 심근관류 SPECT는 관상동맥 질환의 진단에서 adenosine이나 dipyridamole을 이용했을 때보다 부작용의 발생 빈도 및 부작용의 정도가 낮아 안전하게 사용될 수 있으며 진단 성능도 동등한 것으로 생각된다.

Keywords